Background
==========

The *PLU-1/JARID1B*gene, which is upregulated in breast cancers, encodes for a 1,544-amino-acid multidomain protein that is exclusively localised to the nucleus. The protein contains several conserved domains, including the ARID DNA binding domain, both N and C jumonji domains, three PHD domains and putative nuclear localisation signals, indicating that it could regulate the transcription of specific genes either through direct binding or through other transcription factors \[[@B1],[@B2]\].

In this study, we aim to identify the target genes regulated by PLU-1/JARID1B and the possible mechanism of PLU-1/JARID1B-mediated transcriptional regulation.

Methods
=======

Co-immunolocalisation and/or co-immunoprecipitation of PLU-1/JARID1B with HDACs were carried out using anti Myc/HisA antibodies or an antiserum (αPLU-1-C) against PLU-1/Jarid1B after transient transfection of Cos and MCF7 cells with expression vectors coding for Myc or HisA tagged proteins. Direct interactions of PLU-1/JARID1B expressed from a baculovirus with *in vitro*translated HDACs were also demonstrated. *In vitro*mutagenesis and reporter assays were also used. HB2 and MCF7 cells were subjected to microarray using the Affymetrix gene chip HG-U133A after transduction with a recombinant adenovirus or silencing the endogenous gene using a short hairpin RNA (shRNA) expression vector (Imgenex). ChIP assays were carried out using the αPLU-1-C specific antiserum or an antibody against the acetylated form of Histone H3. PCR-assisted DNA binding selection from a random pool of oligonucleotides was carried out using *in vitro*translated full-length PLU-1/JARID1B and GST-PLU-1-ARID.

Results
=======

PLU-1/JARID1B binds to chromatin and the nuclear matrix and localises in MAD bodies when co-transfected with class IIa histone deacetylases (HDACs) or *N*-CoR. Direct binding to class I and class IIa HDACs is demonstrated using co-immunoprecipitation assays and binding of PLU-1/JARID1B to *in vitro*translated HDACs. Two PHD domains in PLU-1 were shown to be crucial for binding to a domain in the N-terminal region of HDAC4 and for the transcriptional repression. Approximately 100 target genes were identified by microarray analysis after overexpressing or silencing the human PLU-1/JARID1B gene in human mammary epithelial cells using adenovirus and RNA interference systems, respectively. Most of the candidate genes were downregulated by PLU-1/JARID1B overexpression, including the *mellathionein*(MT) genes, the *BRCA1*gene, and genes involved in the regulation of the spindle and G2/M checkpoints such as *BUBR1*, *BUB3*, *STK6*, *TTK*, *CDC2*and *Cyclin B1*. ChIP assays confirmed that the MT1H, MT1F and MT1X genes are direct transcriptional targets of PLU-1/JARID1B, and that PLU-1/JARID1B affects the level of acetylation of the promoter of the MT1H gene. Some other candidate genes such as BRCA1 may be downregulated indirectly. The PLU-1/JARID1B ARID domain preferentially binds to a GCACA motif, a putative consensus sequence that is abundant in MT promoters.

Conclusion
==========

The downregulation of the metallothionein genes, checkpoint genes and BRCA1 by PLU-1/JARID1B overexpression is of great interest and could be highly relevant to any role this protein plays in the development and progression of breast cancer.
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